GE HealthCare (GEHC) is establishing the Magnus Neuro Alliance, a research network of institutions using its investigational ultrahigh-gradient, head-only 3T MRI system to study the human brain.
Members include current and future Magnus users at the following sites: Uniformed Services University (Walter Reed), University of Iowa, University of Wisconsin-Madison, Brigham and Women’s Hospital, West China Hospital of Sichuan University, King’s College London, 59th Medical Wing at Joint Base San Antonio-Lackland, University of Rochester, and Stanford University.
The alliance will share protocols, data, and expertise and conduct multisite trials and joint research to study brain microstructure, microvasculature, and function, as well as develop imaging biomarkers for neurological disease, according to the company. Research areas include neurodegenerative disease, brain tumors, traumatic brain injury, multiple sclerosis, and psychiatric illness.
The Magnus system is a technology in development intended for research use only and is not cleared by the U.S. Food and Drug Administration (FDA) or other regulators.
